Business
Perimeter Announces First Quarter 2026 Financial Results
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its first quarter ended March 31, 2026, and provided a corporate update. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"image","alt":"Perimeter Medical Imaging AI logo (CNW Group/Perimeter Medical Imaging AI Inc.)","displaySize":"","headline":null,"caption":"Perimeter Medical Imaging AI logo (CNW Group/Perimeter Medical Imaging AI Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":75,"url":"https://media.zenfs.com/en/prnewswire.com/d60e54f487b3c30fdaf38e6f3e46c8d2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/56qGr7AaT9XLqYmc1YI7uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEzMg--/https://media.zenfs.com/en/prnewswire.com/d60e54f487b3c30fdaf38e6f3e46c8d2","width":400,"height":75},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/Ic4UUobsO3LQiast31.Y0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTEyMA--/https://media.zenfs.com/en/prnewswire.com/d60e54f487b3c30fdaf38e6f3e46c8d2","width":400,"height":75}},"href":"https://mma.prnewswire.com/media/2990196/Perimeter_Medical_Imaging_AI_Inc__Perimeter_Announces_First_Quar.html","hrefExternal":true,"rel":"nofollow","lazy":false},{"type":"text","content":"Conference call/webcast today at 5:00 pm ET","length":43,"tagName":"p","attribs":{}},{"type":"text","content":"TORONTO and DALLAS, May 28, 2026 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its first quarter ended March 31, 2026, and provided a corporate update. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.","length":544,"tagName":"p"},{"type":"text","content":""We continued to execute well across our business in the first quarter of 2026, delivering strong recurring revenue growth via sales to our legacy S-Series OCT users, along with significantly improved operating performance," commented Adrian Mendes, Perimeter's Chief Executive Officer. "Moving forward, buoyed by the first two placements of our next-generation, FDA PMA-approved, AI-enabled Claire™ OCT device, and supported by our recently completed LIFE financing, which was led by healthcare-dedicated institutional investors alongside new and existing investors, we are poised to begin expanding the presence of OCT+AI with...